• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾细胞癌确诊患者的沮丧来源

Sources of Frustration Among Patients Diagnosed With Renal Cell Carcinoma.

作者信息

Bergerot Cristiane Decat, Battle Dena, Bergerot Paulo Gustavo, Dizman Nazli, Jonasch Eric, Hammers Hans J, George Daniel J, Bex Axel, Ljungberg Borje, Pal Sumanta Kumar, Staehler Michael D

机构信息

Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.

Kidney Cancer Research Alliance (KCCure), Alexandria, VA, United States.

出版信息

Front Oncol. 2019 Jan 22;9:11. doi: 10.3389/fonc.2019.00011. eCollection 2019.

DOI:10.3389/fonc.2019.00011
PMID:30723705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6349746/
Abstract

Despite numerous therapeutic advances in renal cell carcinoma (RCC), little is known about patients' perspectives on cancer care. An international survey was conducted to identify points of frustration associated with cancer care reported by patients with RCC. Data were obtained from an online survey, conducted from April 1 to June 15, 2017, through social media and patient networking platforms. This survey obtained baseline demographic, clinicopathologic, and treatment-related information. Open-ended questions accessed sources of frustration in cancer-related care and patients' suggestions for amelioration. Responses were categorized and reviewed by independent reviewers. A qualitative analysis was performed and the Kruskal-Wallis test was used to define associations between baseline characteristics and sources of frustration. Among 450 patients surveyed, 71.5% reported sources of frustration, classified as either emotional (48.4%) or practical (23.1%). The most common were fear of recurrence/progression (15.8%), distrust of their cancer care system (12.9%), and lack of appropriate information (9.8%). Female gender and non-clear cell histology were associated with both types of frustration, and older age was linked to practical sources of frustration. Patients suggested solutions included greater compassion among health care practitioners (20.7%), better access to information (15.1%) and research to improve their chances of being cured (14.7%). Sources of frustration related to emotional and practical causes were identified amongst patients with RCC. Certain demographic and clinical characteristics were associated with more sources of frustration. This study provides the first characterization of specific ways to improve the patient experience by addressing common frustrations.

摘要

尽管肾细胞癌(RCC)的治疗取得了诸多进展,但对于患者对癌症护理的看法却知之甚少。开展了一项国际调查,以确定RCC患者报告的与癌症护理相关的困扰点。数据来自于2017年4月1日至6月15日通过社交媒体和患者网络平台进行的在线调查。该调查获取了基线人口统计学、临床病理和治疗相关信息。开放式问题涉及癌症相关护理中的困扰来源以及患者的改善建议。独立评审员对回答进行分类和审查。进行了定性分析,并使用Kruskal-Wallis检验来确定基线特征与困扰来源之间的关联。在接受调查的450名患者中,71.5%报告了困扰来源,分为情感方面(48.4%)或实际方面(23.1%)。最常见的是对复发/进展的恐惧(15.8%)、对癌症护理系统的不信任(12.9%)以及缺乏适当信息(9.8%)。女性性别和非透明细胞组织学与两种类型的困扰均相关,而年龄较大与实际困扰来源相关。患者提出的解决方案包括医护人员更具同情心(20.7%)、更好地获取信息(15.1%)以及开展研究以提高治愈几率(14.7%)。在RCC患者中确定了与情感和实际原因相关的困扰来源。某些人口统计学和临床特征与更多的困扰来源相关。本研究首次描述了通过解决常见困扰来改善患者体验的具体方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6101/6349746/9c60ce74e3b3/fonc-09-00011-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6101/6349746/9c60ce74e3b3/fonc-09-00011-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6101/6349746/9c60ce74e3b3/fonc-09-00011-g0001.jpg

相似文献

1
Sources of Frustration Among Patients Diagnosed With Renal Cell Carcinoma.肾细胞癌确诊患者的沮丧来源
Front Oncol. 2019 Jan 22;9:11. doi: 10.3389/fonc.2019.00011. eCollection 2019.
2
Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.不同种族文化群体成年癌症患者的姑息治疗体验:一项定性系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):99-111. doi: 10.11124/jbisrir-2015-1809.
3
Understanding the emotions of patients with inadequate response to antidepressant treatments: results of an international online survey in patients with major depressive disorder.理解抗抑郁治疗反应不足的患者的情绪:一项针对重性抑郁障碍患者的国际在线调查结果。
BMC Psychiatry. 2018 Feb 5;18(1):33. doi: 10.1186/s12888-018-1625-y.
4
Life Experience of Patients With Unilateral Vocal Fold Paralysis.单侧声带麻痹患者的生活体验。
JAMA Otolaryngol Head Neck Surg. 2018 May 1;144(5):433-439. doi: 10.1001/jamaoto.2018.0067.
5
Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.促进和支持社区中患有慢性身体疾病的成年人进行自我管理:对医患互动的有效性和意义的系统评价。
JBI Libr Syst Rev. 2009;7(13):492-582. doi: 10.11124/01938924-200907130-00001.
6
Patients' reports of health care practitioner interventions that are related to communication during mechanical ventilation.患者关于医护人员在机械通气期间与沟通相关干预措施的报告。
Heart Lung. 2004 Sep-Oct;33(5):308-20. doi: 10.1016/j.hrtlng.2004.02.002.
7
Communication boards in critical care: patients' views.重症监护中的交流板:患者的看法。
Appl Nurs Res. 2006 Nov;19(4):182-90. doi: 10.1016/j.apnr.2005.09.006.
8
"I want to know everything": a qualitative study of perspectives from patients with chronic diseases on sharing health information during hospitalization.“我想了解一切”:一项关于慢性病患者在住院期间分享健康信息观点的定性研究
BMC Health Serv Res. 2017 Aug 4;17(1):529. doi: 10.1186/s12913-017-2487-6.
9
The difficult doctor? Characteristics of physicians who report frustration with patients: an analysis of survey data.难相处的医生?报告对患者感到沮丧的医生的特征:调查数据分析
BMC Health Serv Res. 2006 Oct 6;6:128. doi: 10.1186/1472-6963-6-128.
10
Information issues for providers of services to people with dementia living in the community in Australia: breaking the cycle of frustration.为澳大利亚社区中患有痴呆症的人提供服务的提供者的信息问题:打破挫折循环。
Health Soc Care Community. 2009 Mar;17(2):141-50. doi: 10.1111/j.1365-2524.2008.00808.x. Epub 2008 Sep 17.

引用本文的文献

1
Patient preferences for adjuvant therapy in renal cell carcinoma: a discrete-choice experiment.肾细胞癌辅助治疗的患者偏好:一项离散选择实验
Future Oncol. 2025 Mar;21(7):843-851. doi: 10.1080/14796694.2025.2463276. Epub 2025 Feb 12.
2
Propensity Score-Matched Analysis of Single Fraction Robotic Radiosurgery Versus Open Partial Nephrectomy in Renal Cell Carcinoma: Oncological Outcomes.肾细胞癌单分割机器人放射外科手术与开放性部分肾切除术的倾向评分匹配分析:肿瘤学结局
Cureus. 2022 Jan 26;14(1):e21623. doi: 10.7759/cureus.21623. eCollection 2022 Jan.
3
"I'm Dealing With That": Illness Concerns of African American and White Cancer Patients While Undergoing Active Cancer Treatments.

本文引用的文献

1
Assessment of Treatment Patterns for Metastatic Renal Cell Carcinoma in Brazil.巴西转移性肾细胞癌治疗模式评估
J Glob Oncol. 2018 Sep;4:1-8. doi: 10.1200/JGO.17.00113. Epub 2017 Dec 27.
2
Updated European Association of Urology Guidelines: Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer.更新后的欧洲泌尿外科协会指南:一线转移性透明细胞肾细胞癌治疗建议
Eur Urol. 2018 Mar;73(3):311-315. doi: 10.1016/j.eururo.2017.11.016. Epub 2017 Dec 7.
3
Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer.
“我正在处理这个问题”:非裔美国癌症患者和白人癌症患者在接受积极癌症治疗期间对疾病的担忧
Am J Hosp Palliat Care. 2021 Jul;38(7):830-841. doi: 10.1177/1049909120969121. Epub 2020 Oct 27.
4
The Effect of Peer Support on Hope Among Patients Under Hemodialysis.同伴支持对血液透析患者希望感的影响。
Int J Nephrol Renovasc Dis. 2020 Mar 13;13:37-44. doi: 10.2147/IJNRD.S240756. eCollection 2020.
基于生物标志物的 Savolitinib 治疗晚期乳头状肾细胞癌的 II 期临床试验。
J Clin Oncol. 2017 Sep 10;35(26):2993-3001. doi: 10.1200/JCO.2017.72.2967. Epub 2017 Jun 23.
4
Treatment options in advanced renal cell carcinoma after first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors.一线使用血管内皮生长因子受体酪氨酸激酶抑制剂治疗后晚期肾细胞癌的治疗选择
Can Urol Assoc J. 2016 Nov-Dec;10(11-12Suppl7):S242-S244. doi: 10.5489/cuaj.4292.
5
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy.辅助舒尼替尼治疗肾切除术后高危肾细胞癌。
N Engl J Med. 2016 Dec 8;375(23):2246-2254. doi: 10.1056/NEJMoa1611406. Epub 2016 Oct 9.
6
Fear of recurrence in long-term cancer survivors-Do cancer type, sex, time since diagnosis, and social support matter?长期癌症幸存者对癌症复发的恐惧——癌症类型、性别、确诊后的时间以及社会支持有影响吗?
Health Psychol. 2016 Dec;35(12):1329-1333. doi: 10.1037/hea0000374. Epub 2016 May 12.
7
Does fear of cancer recurrence differ between cancer types? A study from the population-based PROFILES registry.癌症复发恐惧在不同癌症类型之间是否存在差异?一项基于人群的PROFILES注册研究。
Psychooncology. 2016 Jul;25(7):772-8. doi: 10.1002/pon.4002. Epub 2015 Oct 14.
8
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.纳武单抗与依维莫司治疗晚期肾细胞癌的比较
N Engl J Med. 2015 Nov 5;373(19):1803-13. doi: 10.1056/NEJMoa1510665. Epub 2015 Sep 25.
9
Metastatic non-clear cell renal cell carcinoma: an evidence based review of current treatment strategies.转移性非透明细胞肾细胞癌:当前治疗策略的循证综述
Front Oncol. 2015 Apr 8;5:67. doi: 10.3389/fonc.2015.00067. eCollection 2015.
10
Non-clear cell renal cancer: features and medical management.非透明细胞肾癌:特征与医学管理
J Natl Compr Canc Netw. 2009 Jun;7(6):659-65. doi: 10.6004/jnccn.2009.0046.